Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated

• Status: Completed
• Trial end date: 2012-02-14

Summary

This study will evaluate the safety and efficacy of bimatoprost/timolol fixed combination (GANfort®) versus latanoprost (Xalatan®) in patients with open-angle glaucoma who have never been previously treated and are at high risk for progression.

• Phase: Phase 4

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost; Latanoprost; Ophthalmic Solutions; Pharmaceutical Solutions; Timolol